Immunotherapy Inches Forward in Development of Myeloid Malignancies
Amer Zeidan, MD, MHS, discusses how survival for patients with acute myeloid leukemia and myelodysplastic syndrome remains poor, and although immunotherapy has been positioned as a holy grail, it would be preemptive to predict its future based on the number of small studies that have been performed to date.Source: OncLive
Real-World Treatment Patterns, FLT3 Testing, and Outcomes in AML
Amer Zeidan, MBBS, MHS, Yale University School of Medicine and Yale Cancer Center, New Haven, Connecticut, discusses updated results from an ongoing retrospective study examining FLT3 testing trends, treatment patterns, and overall survival in patients with relapsed/refractory FLT3-positive acute myeloid leukemia (AML).Source: Journal of Clinical Pathways
Francesca Montanari, MD Providing Hematology Expertise at the Smilow Cancer Hospital Care Center at Greenwich
Dr. Francesca Montanari has joined the Smilow Cancer Hospital Care Center at Greenwich as an Assistant Professor of Clinical Medicine (Hematology) and cares for patients with hematologic malignancies.
Convalescent Plasma for Severe COVID-19: D-Dimer Level After Transfusion May Be a Predictive Biomarker of Mortality
Researchers characterized the outcomes seen in patients hospitalized with severe coronavirus disease 2019 (COVID-19) after infusion with convalescent plasma (CP), and the results were presented during the virtual 62nd American Society of Hematology (ASH) Annual Meeting and Exposition.Source: Cancer Therapy Advisor
Dr. Stephanie Halene Appointed Chief of Hematology at Yale Cancer Center and Smilow Cancer Hospital
Following an extensive national search, Stephanie Halene, MD, PhD, has been appointed Chief of Hematology at Yale Cancer Center, Smilow Cancer Hospital and the Yale School of Medicine Department of Internal Medicine.
With Barcoding, a Better Understanding of Life Forms
Because of the very complicated organization of tissues and cells, it’s still not entirely understood how tumors form, for instance, or how different organs emerge in early-stage embryos. To help answer these crucial questions, a team of researchers at Yale have developed a technology that gives a much clearer picture of the spatial relationships in biological systems. The process, which involves barcoding cells in tissue, was developed in the lab of Rong Fan, professor of biomedical engineering. The results were published Nov. 13 in Cell. The authors include Yale BME postdocs, graduate students, and undergraduate students in Fan lab and collaborators from Yale School of Medicine including Prof. Stephanie Halene, interim section chief of hematology.Source: Yale SEAS News